Variations in the risk of breast cancer associated with a family history of breast cancer according to age at onset and reproductive factors.

Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis. J Epidemiol Community Health (1996) 3.09

CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res (2012) 1.12

Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet (1996) 1.08

Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol (1997) 1.04

The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies. Br J Cancer (1998) 0.94

Interactions between genetic and reproductive factors in breast cancer risk in a French family sample. Am J Hum Genet (1997) 0.90

Familial risk, abortion and their interactive effect on the risk of breast cancer--a combined analysis of six case-control studies. Br J Cancer (1995) 0.79

Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79

Isolation of a new human retrovirus from West African patients with AIDS. Science (1986) 7.97

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med (1995) 7.21

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Mol Biol (1990) 4.38

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer (1981) 4.25

HIV-1 reverse transcription. A termination step at the center of the genome. J Mol Biol (1994) 4.15

Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet (1999) 3.43

A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol (1992) 3.39

Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum Reprod (1991) 2.98

Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug. J Gen Virol (1996) 2.95

Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients. J Virol (1998) 2.92

Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature (1987) 2.86

Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet (1981) 2.86

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet (1999) 2.82

Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J Virol (1998) 2.82

Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo. J Virol (1998) 2.55

Major vascular injuries during gynecologic laparoscopy. J Am Coll Surg (1997) 2.50

Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J Virol (1995) 2.45

Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol (2003) 2.42

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med (1987) 2.32

Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug. J Virol (2000) 2.27

Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology (1985) 2.23

Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol (1992) 2.15

Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat Med (2001) 2.13

Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am (1997) 2.09

Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol (1996) 2.08

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. J Virol (2001) 2.08

Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer (1984) 2.07

Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci U S A (1987) 2.02

A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J Virol (1991) 1.90

E3N, a French cohort study on cancer risk factors. E3N Group. Etude Epidémiologique auprès de femmes de l'Education Nationale. Eur J Cancer Prev (1997) 1.89

Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J Virol (2001) 1.79

Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys (1991) 1.77

Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys (1985) 1.74

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer (1984) 1.71

Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis. Cancer Res (2001) 1.67

Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death. J Infect Dis (2001) 1.62

Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol (1989) 1.60

Relative validity and reproducibility of a French dietary history questionnaire. Int J Epidemiol (1997) 1.54

Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy. Ann Oncol (2005) 1.54

Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies. AIDS (1999) 1.52

Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer (1995) 1.51

Modifying risk of developing lung cancer by changing habits of cigarette smoking. Br Med J (Clin Res Ed) (1984) 1.50

Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients. Lancet (1987) 1.49

Deficient LAV1 neutralising capacity of sera from patients with AIDS or related syndromes. Lancet (1985) 1.48

Risk factors for failure of immediate breast reconstruction with prosthesis after total mastectomy for breast cancer. Cancer (1992) 1.46

Kinetic analysis of HIV-1 early replicative steps in a coculture system. AIDS Res Hum Retroviruses (1994) 1.46

Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology (1994) 1.46

Color Doppler energy prediction of malignancy in adnexal masses using logistic regression models. Ultrasound Obstet Gynecol (2002) 1.44

Risk factors for female and male infertility: results of a case-control study. Hum Reprod (1992) 1.41

[Impalpable cancers of the breast. Histological and immunohistochemical study]. Arch Anat Cytol Pathol (1994) 1.40

Wilms' tumor: natural history and prognostic factors: a retrospective study of 248 cases treated at the Institut Gustave-Roussy 1952-1967. Cancer (1976) 1.39

A highly defective HIV-1 group O provirus: evidence for the role of local sequence determinants in G-->A hypermutation during negative-strand viral DNA synthesis. Virology (1995) 1.38

Possible cohort effects in studies on oral contraceptive use and breast cancer. Br J Cancer (1985) 1.38

Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J Virol (1997) 1.38

Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.O.P.). Cancer (1976) 1.32

[The partogram: a well-known tool useful for assessing quality of obstetric care]. J Gynecol Obstet Biol Reprod (Paris) (2007) 1.31

Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer (2003) 1.29

Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer (1997) 1.29

Reappraisal of breast hamartomas. A morphological study of 41 cases. Pathol Res Pract (1994) 1.29

Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer (1995) 1.27

Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Virology (1996) 1.26

A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol (1986) 1.25

[Idiopathic granulomatous mastitis. Review of the literature illustrated by 4 cases]. J Gynecol Obstet Biol Reprod (Paris) (1999) 1.22

Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy. AIDS (1999) 1.20

[Could treatments with beta-blockers be associated with a reduction in cancer risk?]. Rev Epidemiol Sante Publique (2004) 1.19

Decreased mortality among male prisoners. Lancet (1987) 1.18

Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer (1990) 1.18

HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer (2013) 1.17

Cryopreservation of spermatozoa: a 1996 review. Hum Reprod Update (1997) 1.17

Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol (1987) 1.15

Lung cancer and use of cigarettes: a French case-control study. J Natl Cancer Inst (1985) 1.15

Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG (2010) 1.14

Risk factors for breast cancer according to age at diagnosis in a French case-control study. J Clin Epidemiol (1990) 1.14

Effects of human immunodeficiency virus type 1 resistance to protease inhibitors on reverse transcriptase processing, activity, and drug sensitivity. J Virol (1999) 1.13

Lymph node invasion and prognosis in nephroblastoma. Cancer (1980) 1.13

Acupuncture in gastroscopy. Lancet (1978) 1.11

Evaluation of the quality of care for severe obstetrical haemorrhage in three French regions. BJOG (2001) 1.10

Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS (1997) 1.10

Sexually transmitted diseases as major causes of ectopic pregnancy: results from a large case-control study in France. Fertil Steril (1994) 1.10

Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat (2000) 1.09

Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000. Eur J Cancer Prev (2005) 1.09

C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet (1987) 1.08

[Gynecology-obstetrics: one and indivisible]. J Gynecol Obstet Biol Reprod (Paris) (2004) 1.07

Helping people to stop smoking: randomised comparison of groups being treated with acupuncture and nicotine gum with control group. Br Med J (Clin Res Ed) (1985) 1.07

Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. J Natl Cancer Inst (1994) 1.05

Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Clin Cancer Res (2000) 1.04

Education program for general practitioners on breast and cervical cancer screening: a randomized trial. PRE.SA.GF Collaborative Group. Rev Epidemiol Sante Publique (1995) 1.04

Multicentred controlled trial of cervical cerclage in women at moderate risk of preterm delivery. Br J Obstet Gynaecol (1984) 1.03

Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine. J Infect Dis (2001) 1.03

CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. Am J Clin Pathol (1995) 1.03

The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis. J Gen Virol (1998) 1.02